Shri Ahimsa Naturals share price today

Shri Ahimsa Naturals Ltd's share price was ₹400.00 at the close on 4 November 2026. It has been rising for 79 weeks. That is 12.7% above its average price over the last 200 trading days. In the last 52 weeks it traded between ₹222 and ₹494, and at that close it sat 65% of the way up from that low.

A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). Today Shri Ahimsa Naturals Ltd is in stage 2. The phase helps read everything below.

Over the past 13 weeks it has done better than the NIFTY 500, and it has stayed ahead for 14 weeks in a row.

Over the last 1 year the share price moved +171% while the NIFTY 500 moved +8%, so it is ahead of the index over that whole period. The chart above shows the 13-week comparison for every week.

This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.

Two changes stood out: foreign funds (FIIs) cut their stake for 3 quarters in a row and number of shareholders up 52% in a year.

1. Foreign funds (FIIs) cut their stake for 3 quarters in a row

   From 3% to 0.3% of the company by the September 2026 quarter.

2. Number of shareholders up 52% in a year

   1,457 shareholders in the September 2026 quarter, against 958 a year earlier.

For January to March 2026 (the quarter ended 31 March 2026), Shri Ahimsa Naturals reported revenue of ₹63.0 crore, up 14.5% from ₹55.0 crore a year earlier, and a profit of ₹15.0 crore, up 25.0% from ₹12.0 crore.

Shri Ahimsa Naturals results: January to March 2026 against a year earlier

The next results, for April to June 2026, were due by 14 August 2026: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter). This page shows them once our weekly data update has read them.

From the company's reported quarterly results (quarter ended 31 March 2026). Revenue and profit in ₹ crore.

Shri Ahimsa Naturals closed at ₹400.00 on 4 November 2026, up 49.9% from ₹266.80 a year earlier (7 November 2025). Its highest weekly close since April 2025 was ₹493.75 on 28 August 2026.

Shri Ahimsa Naturals share price: then and now

Weekly closing prices. Each change is the move from that price to the 4 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes.

90 weekly closes from 4 April 2025 to 4 November 2026.

4 Nov 2026: Shri Ahimsa Naturals closed at ₹400.00, up 0.0% on the week and down 5.3% on the month. Results for January to March 2026: Revenue up 14.5% and profit up 25.0% on a year earlier.

Shri Ahimsa Naturals has paid no dividend on the NSE since its first NSE close in our records (4 April 2025), the start of the period we checked.

No. Shri Ahimsa Naturals Ltd paid out 0% of its profit as dividends in each of its last 4 reported years, so there is no payout history to show. That comes from the filed annual statements, not an estimate.

From the NSE corporate-actions record, read 5 November 2026.

Shri Ahimsa Naturals is not on any of our India lists this week.

Shri Ahimsa Naturals Ltd earned ₹15.0 Cr of net profit in the Mar 2026 quarter, +25.0% on the same quarter a year earlier. That is the 2nd quarter in a row of profit growth. Full-year FY26 profit was ₹29.0 Cr. Over 3 years profit has grown −8.6% a year on average. That is 23.8% of the quarter's revenue.

Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.

For the full year, FY26 profit was ₹29.0 Cr (+31.8% on the year before).

Shri Ahimsa Naturals Ltd reported ₹63.0 Cr of revenue in the Mar 2026 quarter, +14.5% on the same quarter a year earlier. That is the 2nd quarter in a row with growth on the year before. Over 3 years it has grown 5.8% a year on average. The last full year, FY26, came in at ₹123 Cr.

Revenue is everything the company billed its customers in the period.

FY26 revenue was ₹123 Cr, +28.1% on the year before.

Recent pace: the last four quarters grew +31.6% on average, against 5.8% a year over the longer run, so this year is growing faster than its own long-run rate.

Shri Ahimsa Naturals Ltd's operating margin was 28.0% in the Mar 2026 quarter, 2.0 percentage points lower than the same quarter a year ago. Across 4 years it has been between 29.0% and 48.0%. The latest quarter is below every full year in that period.

Operating margin is what is left from every ₹100 of sales after the costs of running the business, before interest and tax. It shows pricing power and cost control.

Why: the operating margin move is clear, but the cost details behind it are not in our data, so we show the move without guessing the reason.

Over the last 3 years, 40% of Shri Ahimsa Naturals Ltd's reported profit came in as cash from its operations, a gap worth watching. In FY26 it brought in ₹9.0 Cr of operating cash against ₹29.0 Cr of profit. After ₹15.0 Cr of spending on assets, free cash was −₹6.0 Cr: it spent more than its operations brought in.

The profit and loss account shows what was earned. The cash-flow statement shows the cash that actually came in. Comparing operating cash flow with profit is one of the best checks that a profit is real.

Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year.

Why 40% of profit came in as cash: the cash cycle got 123 days longer between FY23 and FY26, so more of each rupee of profit waits in the business before it arrives. When less than 70% of profit comes in as cash, it is the thing to watch on this page.

What to look at next: less of the profit turns into cash than it should, and the cash cycle is 123 days longer. The next section looks at where the cash is stuck.

Shri Ahimsa Naturals Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 277 days in FY26, up from 154 days in FY23. It spent ₹37.0 Cr on assets over the last 3 years. Customers take 86 days to pay, and stock sits for 193 days on average.

Working capital is the cash tied up between paying suppliers and getting paid. Debtor days: how long customers take to pay. Inventory days: how long stock sits. The cash cycle: the whole loop, in days of sales.

At FY26 sales of ₹123 Cr, each day of that cycle ties up about ₹0.3 Cr, so roughly ₹93.0 Cr is tied up in the business at any time.

FY26: customers took 86 days to pay and stock sat for 193 days, about 6.3 months of sales sitting as stock, for a full cycle of 277 days, longer than FY23's 154.

The full loop: cash goes out to suppliers and production on day 0. Stock sits for 193 days. Customers pay about 86 days after that. Suppliers are paid at 2 days. Together that makes the 277-day cycle.

Spending on assets: ₹37.0 Cr over the last 3 years, against ₹5.0 Cr of depreciation (the yearly wear and tear on existing assets). So it is building well beyond replacing what wears out. Work still in progress is ₹18.0 Cr (FY26): assets paid for that are not earning yet.

In short: cash is getting stuck in the daily cycle, so watch the cycle more than the profit.

Shri Ahimsa Naturals Ltd's P/E is 32.8×, near the high end of its own history: higher than 96% of past readings. Its usual P/E (the middle reading) is 21.1×, over 1 year of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth.

P/E is the share price divided by a year's profit per share: how many rupees the market pays for each rupee of yearly profit.

Why the multiple is where it is: over the past year earnings per share moved +32.3% while the price moved +49.9%. The price did better than earnings, which pushed the multiple up within its own range.

In short: the multiple is high against its own past, so the earnings trend underneath matters more than the multiple.

Shri Ahimsa Naturals Ltd's business trend cannot be read yet. There are fewer than eight usable quarters of growth figures, so there is not enough history to read the trend.

Every business is somewhere on a path of getting better or worse, and this section names where. The last 12 quarters of growth in revenue, profit and earnings per share, plus the return the business earns on its capital, are read as lines. Getting worse: the lines are falling. Turning around: a low point has just formed and the last few quarters are rising from it. Getting better: the rise from the low has lasted. Growing steadily: steady growth with healthy returns. Slowing from a peak: still high, but slowing. When the lines disagree the result is mixed; too little history means no reading. CAGR (compound annual growth rate) is the steady yearly rate that would turn the starting value into the latest one. It is the fairest way to compare growth over different periods. If the 1-year figure is much bigger than the 10-year one, recent growth is running faster than the long-run trend. A dash means there is no figure for that period, or the starting year was a loss, where a growth rate means nothing.

Why it matters: with too little history, we say so rather than guess a direction.

One or more growth lines have an extreme jump caused by comparing with a near-zero or loss-making quarter. Those jumps are capped before reading and drawn at the edge of the chart, so one odd quarter does not decide the result.

The return figures here are yearly, not quarterly. They show level and direction only; they can support the growth lines but never decide the reading alone.

There are fewer than eight usable quarters, so this page does not guess a direction from so little history.

Compound annual growth rate (%)

Compound annual growth rate over each period, %. Revenue, profit and EPS come from yearly figures; the share price row is price growth over the same periods. A dash means no figure for that period, or the starting year was a loss.

Shri Ahimsa Naturals Ltd earned a ROCE of 22% in FY26. Its return on capital used (ROIC) is 2.8 percentage points above its cost of capital, so growth here adds value, not just size. It comes from a 23.6% net margin and 0.56× asset turnover (sales divided by assets).

Return on capital employed (ROCE) is the profit the whole business earns on all the money in it, from shareholders and lenders together. It is the best single test of whether growth adds value or just size.

Why the return is what it is (FY26): a 23.6% net margin × 0.56× asset turnover × 1.13× leverage (assets divided by equity) ≈ 14.9% on equity. The margin does most of the work; borrowing plays a small part, so this return is earned, not borrowed.

The key test, return on capital used minus the cost of capital: 14.8% − 12.0% = +2.8 percentage points. The 12.0% is a standard assumption for the cost of capital in India, not an estimate for this company. Read the sign and size of the gap, not the decimals. Positive but thin: it creates value with little room for error.

The 14.8% ROIC above is the latest reading, as reported. The yearly chart below shows FY26 at 20.6%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method.

Shri Ahimsa Naturals Ltd had ₹20.0 Cr of borrowings against ₹193 Cr of equity in FY26, so its debt is 0.10× its equity. Its operating profit is 36 times its interest bill. Over 3 years borrowings went from ₹3.0 Cr to ₹20.0 Cr. Over the last 3 of those years it spent ₹37.0 Cr on assets.

Debt-to-equity shows how much of the business is paid for with borrowed money. Interest cover shows how many times operating profit pays the interest bill. Low debt and high cover are the safe combination.

Part of the spending on assets is being paid for with borrowed money.

Foreign institutions cut their stake in Shri Ahimsa Naturals Ltd by 2.8 percentage points over 4 quarters, the biggest change among its owners. Foreign institutions now own 0.3% of the company. Domestic institutions moved −2.7 points over the same period, to 5.9%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings.

Who owns the company each quarter: promoters (the founders or controlling owners), foreign institutions, domestic institutions such as mutual funds, and the public. When people close to the business steadily raise their stake, that is worth noticing; a quiet list is also an answer.

Over the last two years: Foreign institutions: −2.8 points over 4 quarters, to 0.3%; Domestic institutions: −2.7 points over 4 quarters, to 5.9%; Promoters: −0.9 points over 4 quarters, to 67.8%.

Why the owners changed: foreign institutions drove it (−2.8 points), together with domestic institutions (−2.7 points). They reduced their stake.

For Shri Ahimsa Naturals Ltd, the Z-score is 14.11. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is well clear of danger. It estimates how far the balance sheet is from trouble; it is not a forecast of failure.

The Z-score estimates how far a company is from balance-sheet trouble. Above about 3 is safe; below about 1.8 is the danger zone. It was built for manufacturers, so it is not used for banks and lenders.

Why it matters: a Z-score of 14.11 is well clear of the danger zone, so the balance sheet is not the risk here.

56.8 out of 100, rank 19 of 20 in Chemicals - Organic, with 47% of the evidence available. It is provisional, so it is ranked below companies with full evidence.

Shri Ahimsa Naturals Ltd scores 56.8 out of 100 against the 20 companies it is compared with in Chemicals - Organic, ranking 19. Some evidence is missing, so the score is pulled toward the middle on purpose.

The four parts add up to the total exactly: 16.5 + 17.2 + 9.7 + 13.4 = 56.8. This is the same number shown on the industry page; it is worked out once for the whole group and read here.

What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector.

Shri Ahimsa Naturals ranks 19 of 20 Chemicals - Organic companies on the 4-Factor Sector Score, with 56.8 out of 100.

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read.

The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section.

Related companies: Chemicals - Organic, all 20 compared on one page.

Shri Ahimsa Naturals is the 12th largest of 20 Chemicals - Organic companies on Sector Alpha by market value (scores of 30 October 2026). Just above it: Citurgia Biochemicals, Sigachi Industries and Jyoti Resins and Adhesives. Just below it: Sacheerome, Indo Amines and Valiant Organics.

Chemicals - Organic companies close in size

9. Citurgia Biochemicals Ltd ₹1,449 crore
10. Sigachi Industries Ltd ₹1,007 crore
11. Jyoti Resins and Adhesives Ltd ₹1,006 crore
12. Shri Ahimsa Naturals Ltd ₹952 crore
13. Sacheerome Ltd ₹922 crore
14. Indo Amines Ltd ₹865 crore
15. Valiant Organics Ltd ₹864 crore

All 20 Chemicals - Organic companies, largest first

Companies close in size in other industries

1621. Western Carriers (India) Ltd ₹960 crore · Logistics
1622. Premier Polyfilm Ltd ₹953 crore · Plastics - Sheets/Films
1623. Shri Ahimsa Naturals Ltd ₹952 crore
1624. GKW Ltd ₹950 crore · Miscellaneous
1625. Tembo Global Industries Ltd ₹950 crore · Trading

Sector Alpha, written by code from the published numbers. Data as of 4 November 2026.

Every chart on this page is drawn by code from the published figures, with no forecasts and no price opinions.

See the plain-text version of this page.